Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs, Volume 3 - Number 1



Prostate Cancer Molecular Background: The IGF-1Ec Story

, 3(1): 6 - 15

Armakolas Athanasios and Koutsilieris Michael


DOI: 10.2174/2212697X03666151203202720



Castration-resistant Prostate Cancer: The Targeting of Bone Microenvironment-related Survival Factors For Prostate Cancer Cells

, 3(1): 16 - 22

Dimitrios Karamanolakis, Athanasios Armakolas and Michael Koutsilieris


DOI: 10.2174/2212697X03666151203202934



Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 3(1): 23 - 35

Lavinia Casati, Fabio Celotti and Valeria Sibilia


DOI: 10.2174/2212697X03666151207185452



Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 3(1): 36 - 62

Festuccia Claudio


DOI: 10.2174/2212697X0301160328201324



Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies

, 3(1): 63 - 73

Jianquan Wu, Chengcheng Hong, Hongjie Pan, Qingzhu Yang, Yu Mei, Q. Ping Dou and Huanjie Yang


DOI: 10.2174/2212697X03666160112001739





Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Advertisement

Lung Cancer Awareness Month

Related Journals

Related eBooks

eBooks Catalog